[Clinical effectiveness of nadroparin calcium in the surgical treatment of breast cancer].

Article Details

Citation
Copy to clipboard

Iaremchuk AIa, Zotov AS, Cheshuk VE, Anikuc'ko NF, Zakhartseva LM, Diatel MV, Kravchenko AV, Lobanova OE, Sidorchuk OI

[Clinical effectiveness of nadroparin calcium in the surgical treatment of breast cancer].

Vopr Onkol. 2003;49(2):205-8.

PubMed ID
12785206 [ View in PubMed
]
Abstract

The report deals with an assessment of frequency of fatal thromboembolic complications after surgery for breast cancer, in particular, frequency and severity of the side-effects of calcium nadroparin treatment as a component of surgical preparation. Considering the low incidence of thromboembolic complications in such patients and the side-effects of anti-coagulant therapy, it is suggested that decisions be made on a strictly individual basis under stringent clinical control.

DrugBank Data that Cites this Article

Drugs